NCT05840575Recruiting
Investigating Cognitive Impairment in Young Patients With Cancer Prospectively
A Multidisciplinary Neuroscience Approach to Investigate Cognitive Impairment in Young Patients With Cancer Prospectively
Source: ClinicalTrials.gov · Last updated 3 May 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The MyBrain study investigates the brain function of children, adolescents and young adults during and after chemo treatment for cancer. The tests include 1) cognitive skills such as memory and attention; 2) the brain's electrical activity; 3) and biological markers related to brain function. The aim of the study is to better understand the trajectories of cognitive functioning and measures that have been associated with cognitive impairment in patients treated with chemotherapy.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 25 Jan 2023
- Start date
- 1 Mar 2022
- Primary completion date
- 1 Mar 2027
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Diseases
- Hodgkin lymphoma, Childhood cancers, Sarcoma
- NCT number
- NCT05840575
What you commit to
- Study type: Observational
- Planned participants: 100
- From 1 Mar 2022 to the primary completion date, 1 Mar 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Have had a previous chemotherapy or radiotherapy treatment
Other illness
- Severe intellectual disability or mental health disorder that hinders participation
- Terminal illness
Other
- Unable to speak and understand Danish
- Brain metastases,
Who the study is looking for
- Patients who are newly diagnosed with a non-CNS cancer and will undergo chemotherapy at University Hospital Copenhagen, Rigshospitalet.
- At the age of 7-29 years at diagnosis
- Each patient is matched (1:1) with a control participant within 24 months of age. The controls are recruited from the patient's own social circle and can be a friend, partner, or close family (sibling or cousin).
Age in the registry: 7 years to 29 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rigshospitalet Coordinator of this site? Confirm its status | Copenhagen | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.